Cargando…
A 16-week study to compare the effect of vildagliptin versus gliclazide on postprandial lipoprotein concentrations and oxidative stress in patients with type 2 diabetes inadequately controlled with metformin monotherapy
BACKGROUND: Diabetes is closely linked with coronary artery disease, either by means of direct effects of hyperglycemia, or indirectly by its frequent association with dyslipidemia. Any treatment for diabetes that has beyond the capacity of reduce glycated hemoglobin, the propensity to improve lipid...
Autores principales: | Hissa, Marcelo R. Nasser, Cavalcante, Lilian Loureiro Albuquerque, Guimarães, Sergio Botelho, Hissa, Miguel Nasser |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4499917/ https://www.ncbi.nlm.nih.gov/pubmed/26170902 http://dx.doi.org/10.1186/s13098-015-0058-8 |
Ejemplares similares
-
Use of continuous glucose monitoring system in patients with type 2 mellitus diabetic during hemodialysis treatment
por: Hissa, Marcelo Rocha Nasser, et al.
Publicado: (2021) -
Treatment Compliance with Fixed-Dose Combination of Vildagliptin/Metformin in Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Metformin Monotherapy: A 24-Week Observational Study
por: Rombopoulos, Grigorios, et al.
Publicado: (2015) -
Brazilian multicenter study for the evaluation of patients’ satisfaction of blood glucose self-monitoring with BGStar(®) blood glucose meter in insulinized patients with diabetes mellitus type 1 and 2
por: Hissa, Miguel Nasser
Publicado: (2016) -
The Efficacy and Safety of Saxagliptin When Added to Metformin Therapy in Patients With Inadequately Controlled Type 2 Diabetes With Metformin Alone
por: DeFronzo, Ralph A., et al.
Publicado: (2009) -
Effects of Vildagliptin or Pioglitazone on Glycemic Variability and Oxidative Stress in Patients with Type 2 Diabetes Inadequately Controlled with Metformin Monotherapy: A 16-Week, Randomised, Open Label, Pilot Study
por: Kim, Nam Hoon, et al.
Publicado: (2017)